best spot to inject semaglutide The 3 Most Common GLP-1 Injection Sites Does it matter where you

These numbers explain why a recent poll found that one in eight adults in the US say they use GLP-1 drugs, many for weight loss and others for diabetes

Pfizer's danuglipron, once considered the primary competitor, was discontinued in April 2025 after a case of potential drug-induced liver injury in a dose-optimization study, following the earlier termination of lotiglipron in 2023 for similar hepatic concerns

References 1 Growth Hormone & IGF ResearchLong-Arg3-IGF-1: structure, reduced IGF binding-protein affinity, and extended biological activity of the analog

The potential health risks, ethical considerations, and lack of comprehensive regulatory oversight should not be overlooked